Johnson & Johnson- 詳細介紹、公司背景、業務範圍、財務數據以及市場表現

關於 Johnson & Johnson 公司

公司簡介

公司代碼JNJ

公司名稱Johnson & Johnson

上市日期Sep 25, 1944

成立日期1887

CEOMr. Joaquin Boix Duato

員工數量138100

證券類型Ordinary Share

年結日Sep 25

公司地址One Johnson & Johnson Plaza

城市NEW BRUNSWICK

上市交易所NYSE Consolidated

國家United States of America

郵編08933

電話17325242455

網址https://www.jnj.com/

公司代碼JNJ

上市日期Sep 25, 1944

成立日期1887

公司高階主管

名稱

名稱/職務

職務

持股

持股變動

Mr. Joaquin Boix Duato

Chairman of the Board, Chief Executive Officer

407.70K

+11.95%

Ms. Jennifer L. Taubert

Executive Vice President, Worldwide Chairman, Innovative Medicine

178.01K

+14.96%

Ms. Kathryn E. Wengel

Executive Vice President, Chief Technology Officer and Risk Officer

94.62K

+14.54%

Ms. Vanessa Broadhurst

Executive Vice President - Global Corporate Affairs

23.59K

+18.96%

Mr. Joseph J. Wolk

Chief Financial Officer, Executive Vice President

16.04K

+683.59%

Prof. Dr. John C. Reed, M.D., Ph.D.

Executive Vice President - Innovative Medicine, Research and Development

15.54K

+6.62%

Ms. Kristen Mulholland

Chief Human Resource Officer

14.11K

+20.79%

Ms. Elizabeth (Liz) Forminard

Executive Vice President, General Counsel

10.90K

+30.72%

Ms. Anne M. Mulcahy

Independent Director

8.09K

+1.52%

Mr. Hubert Joly

Independent Director

5.00K

--

名稱

名稱/職務

職務

持股

持股變動

Mr. Joaquin Boix Duato

Chairman of the Board, Chief Executive Officer

407.70K

+11.95%

Ms. Jennifer L. Taubert

Executive Vice President, Worldwide Chairman, Innovative Medicine

178.01K

+14.96%

Ms. Kathryn E. Wengel

Executive Vice President, Chief Technology Officer and Risk Officer

94.62K

+14.54%

Ms. Vanessa Broadhurst

Executive Vice President - Global Corporate Affairs

23.59K

+18.96%

Mr. Joseph J. Wolk

Chief Financial Officer, Executive Vice President

16.04K

+683.59%

Prof. Dr. John C. Reed, M.D., Ph.D.

Executive Vice President - Innovative Medicine, Research and Development

15.54K

+6.62%

收入明細

單位: USD更新時間: 3月5日週三

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

業務USD

名稱

營收

佔比

Oncology-DARZALEX

11.67B

13.13%

Immunology-STELARA

10.36B

11.66%

Interventional Solutions

7.70B

8.67%

Surgery-General

5.35B

6.03%

Surgery-Advanced

4.48B

5.05%

Other

49.23B

55.43%

地區USD

名稱

營收

佔比

United States

50.30B

56.63%

International

38.51B

43.36%

Europe

20.21B

22.75%

Asia-Pacific, Africa

13.59B

15.30%

Western Hemisphere, excluding U.S.

4.71B

5.30%

業務

地區

業務USD

名稱

營收

佔比

Oncology-DARZALEX

11.67B

13.13%

Immunology-STELARA

10.36B

11.66%

Interventional Solutions

7.70B

8.67%

Surgery-General

5.35B

6.03%

Surgery-Advanced

4.48B

5.05%

Other

49.23B

55.43%

股東統計

更新時間: 2月21日週五

持股股東

股東類型

持股股東

股東統計

佔比

The Vanguard Group, Inc.

9.62%

State Street Global Advisors (US)

5.58%

BlackRock Institutional Trust Company, N.A.

5.39%

Geode Capital Management, L.L.C.

2.39%

State Farm Insurance Companies

1.31%

Other

75.67%

持股股東

股東統計

佔比

The Vanguard Group, Inc.

9.62%

State Street Global Advisors (US)

5.58%

BlackRock Institutional Trust Company, N.A.

5.39%

Geode Capital Management, L.L.C.

2.39%

State Farm Insurance Companies

1.31%

Other

75.67%

股東類型

股東統計

佔比

Investment Advisor/Hedge Fund

33.35%

Investment Advisor

28.92%

Research Firm

2.91%

Pension Fund

2.28%

Bank and Trust

2.11%

Insurance Company

1.50%

Sovereign Wealth Fund

1.36%

Hedge Fund

0.74%

Foundation

0.43%

Other

26.35%

機構持股

更新時間: 2月20日週四

報告期間

機構數

持股數

持股佔比

持股變動

2025Q1

5790

1.78B

74.05%

+2.88M

2024Q4

5953

1.78B

74.14%

+8.27M

2024Q3

5699

1.76B

73.47%

+2.69M

2024Q2

5691

1.75B

72.75%

+9.12M

2024Q1

5685

1.72B

71.58%

-6.08M

2023Q4

5686

1.71B

71.40%

-7.80M

2023Q3

5524

1.71B

71.21%

-159.24M

2023Q2

5528

1.86B

71.81%

+6.27M

2023Q1

5490

1.85B

71.21%

-28.44M

2022Q4

5447

1.87B

71.55%

+6.53M

股東持股明細

名稱

持股數

佔比

持股變動

變動比例

公告日期

The Vanguard Group, Inc.

231.81M

9.62%

+1.80M

+0.78%

Dec 31, 2024

State Street Global Advisors (US)

134.45M

5.58%

+210.34K

+0.15%

Dec 31, 2024

BlackRock Institutional Trust Company, N.A.

130.00M

5.39%

+2.11M

+1.65%

Dec 31, 2024

Geode Capital Management, L.L.C.

57.66M

2.39%

+1.56M

+2.78%

Dec 31, 2024

State Farm Insurance Companies

31.67M

1.31%

--

Dec 31, 2024

Norges Bank Investment Management (NBIM)

30.35M

1.26%

+1.26M

+4.34%

Dec 31, 2024

Wellington Management Company, LLP

24.35M

1.01%

+431.20K

+1.80%

Dec 31, 2024

JP Morgan Asset Management

24.04M

0.99%

+5.40M

+28.99%

Dec 31, 2024

Morgan Stanley Smith Barney LLC

22.90M

0.95%

-654.87K

-2.77%

Dec 31, 2024

BlackRock Asset Management Ireland Limited

19.87M

0.82%

+587.38K

+3.04%

Dec 31, 2024

持股ETF

更新時間: 21 小時前

機構名稱

佔比

iShares U.S. Pharmaceuticals ETF

23.94%

Future Fund Active ETF

13.01%

Franklin Income Focus ETF

8.56%

Federated Hermes MDT Large Cap Value ETF

7.68%

American Century Focused Large Cap Value ETF

7.36%

Health Care Select Sector SPDR Fund

7.35%

Proshares Ultra Health Care

6.65%

VanEck Pharmaceutical ETF

6.59%

iShares Core High Dividend ETF

6.57%

iShares U.S. Healthcare ETF

6.41%

iShares U.S. Pharmaceuticals ETF

佔比23.94%

Future Fund Active ETF

佔比13.01%

Franklin Income Focus ETF

佔比8.56%

Federated Hermes MDT Large Cap Value ETF

佔比7.68%

American Century Focused Large Cap Value ETF

佔比7.36%

Health Care Select Sector SPDR Fund

佔比7.35%

Proshares Ultra Health Care

佔比6.65%

VanEck Pharmaceutical ETF

佔比6.59%

iShares Core High Dividend ETF

佔比6.57%

iShares U.S. Healthcare ETF

佔比6.41%

分紅派息

近5年累計派現 56.78B 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

Jan 02, 2025

JNJ.NB Interim Cash Dividend of gross USD 1.24 paid on Mar 04, 2025 going ex on Feb 18, 2025

Feb 18, 2025

Mar 04, 2025

Feb 18, 2025

Oct 15, 2024

JNJ.NB Final Cash Dividend of gross USD 1.24 paid on Dec 10, 2024 going ex on Nov 26, 2024

Nov 26, 2024

Dec 10, 2024

Nov 26, 2024

Jul 17, 2024

JNJ.NB Interim Cash Dividend of gross USD 1.24 paid on Sep 10, 2024 going ex on Aug 27, 2024

Aug 27, 2024

Sep 10, 2024

Aug 27, 2024

Apr 16, 2024

JNJ.NB Interim Cash Dividend of gross USD 1.24 paid on Jun 04, 2024 going ex on May 20, 2024

May 21, 2024

Jun 04, 2024

May 20, 2024

Jan 02, 2024

JNJ.NB Interim Cash Dividend of gross USD 1.19 paid on Mar 05, 2024 going ex on Feb 16, 2024

Feb 20, 2024

Mar 05, 2024

Feb 16, 2024

Oct 19, 2023

JNJ.NB Final Cash Dividend of gross USD 1.19 paid on Dec 05, 2023 going ex on Nov 20, 2023

Nov 21, 2023

Dec 05, 2023

Nov 20, 2023

Jul 20, 2023

JNJ.NB Interim Cash Dividend of gross USD 1.19 paid on Sep 07, 2023 going ex on Aug 25, 2023

Aug 28, 2023

Sep 07, 2023

Aug 25, 2023

Apr 18, 2023

JNJ.NB Interim Cash Dividend of gross USD 1.19 paid on Jun 06, 2023 going ex on May 22, 2023

May 23, 2023

Jun 06, 2023

May 22, 2023

Jan 03, 2023

JNJ.NB Interim Cash Dividend of gross USD 1.13 paid on Mar 07, 2023 going ex on Feb 17, 2023

Feb 21, 2023

Mar 07, 2023

Feb 17, 2023

Oct 18, 2022

JNJ.NB Final Cash Dividend of gross USD 1.13 paid on Dec 06, 2022 going ex on Nov 21, 2022

Nov 22, 2022

Dec 06, 2022

Nov 21, 2022

拆合股

公告日期

類型

比率

暫無數據

公告日期

類型

比率

暫無數據

Johnson & Johnson

165.120USD

Johnson & Johnson

165.120

概覽

公司